Expert Statement: Vivi Hollertt, Nouryon
The European Chemical Industry has set out on an ambitious path to become carbon neutral.
Interview
Expert Statement: Clemens Mittelviefhaus, Yncoris
The European Chemical Industry has set out on an ambitious path to become carbon neutral.
Expert Statement: Frank Hyldmar, Currenta
The European Chemical Industry has set out on an ambitious path to become carbon neutral.
Expert Statement: Thomas Wagner, GETEC
The European Chemical Industry has set out on an ambitious path to become carbon neutral.
Expert Statement: Jürgen Vormann, Infraserv
The European Chemical Industry has set out on an ambitious path to become carbon neutral.
Expert Statement: Bernhard Kott, Symrise
The European Chemical Industry has set out on an ambitious path to become carbon neutral.
Expert Statement: Heinz-Jürgen Bertram, Symrise
The European Chemical Industry has set out on an ambitious path to become carbon neutral.
Expert Statement: Samia Nehme, Shell Chemicals
The European Chemical Industry has set out on an ambitious path to become carbon neutral.
Expert Statement: Mark Williams, SABIC
The European Chemical Industry has set out on an ambitious path to become carbon neutral.
Expert Statement: Matthias Braun, Sanofi-Aventis Germany
The European Chemical Industry has set out on an ambitious path to become carbon neutral.
Expert Statement: Herwig Buchholz, Merck
The European Chemical Industry has set out on an ambitious path to become carbon neutral.
Expert Statement: Zanna McFerson, Avantium
The European Chemical Industry has set out on an ambitious path to become carbon neutral.
Expert Statement: Ralf Brinkmann, Dow Germany
The European Chemical Industry has set out on an ambitious path to become carbon neutral.
Expert Statement: Wijnand Bruinsma, AkzoNobel
The European Chemical Industry has set out on an ambitious path to become carbon neutral.
Expert Statement: Bernhard Hettich, CHT Group
The European Chemical Industry has set out on an ambitious path to become carbon neutral.
Expert Statement: Stefan Haver, Evonik
The European Chemical Industry has set out on an ambitious path to become carbon neutral.
Expert Statement: Hubert Fink, Lanxess
The European Chemical Industry has set out on an ambitious path to become carbon neutral.
Expert Statement: Christian Haessler, Covestro
The European Chemical Industry has set out on an ambitious path to become carbon neutral.
Expert Statement: Richard Haldimann, Clariant
The European Chemical Industry has set out on an ambitious path to become carbon neutral.
Expert Statement: Walmir Soller, Braskem
The European Chemical Industry has set out on an ambitious path to become carbon neutral.
Expert Statement: Delf Bintakies, Bayer
The European Chemical Industry has set out on an ambitious path to become carbon neutral.
Expert Statement: Lucrèce Foufopoulos, Borealis
The European Chemical Industry has set out on an ambitious path to become carbon neutral.
Expert Statement: Tatsuhiko Tokunaga, Asahi Kasei
The European Chemical Industry has set out on an ambitious path to become carbon neutral.
Expert Statement: Rudolf Staudigl, Wacker Chemie
The European Chemical Industry has set out on an ambitious path to become carbon neutral.
Expert Statement: Uwe Bergmann, Henkel
The European Chemical Industry has set out on an ambitious path to become carbon neutral.
Expert Statement: Martin Babilas, Altana
The European Chemical Industry has set out on an ambitious path to become carbon neutral.
The Coronavirus Crisis: Challenges and Opportunities for CMOs, CDMOs and CROs
The coronavirus crisis caused by the Covid-19 pandemic has uncovered problems that have been smoldering beneath the surface of the pharmaceutical industry — including CMOs/CDMOs and CROs — and need to be addressed. That supply chains are vulnerable to disruption when major development, production and transportation hubs are blocked or shut down has become painfully obvious.
17.09.2020 • Topics • Innovation
Accelerated Drug Discovery
In January, Schrödinger, a provider of integrated software solutions, and the life sciences company Bayer announced a 5-year technology alliance to develop a comprehensive de novo design solution to accelerate the discovery of innovative, high-quality drugs.
The Impact of Covid-19 on the Pharmaceutical Industry
Andrew Badrot, CEO of C2 Pharma and a close observer of pharma industry trends, analyzes the current situation and how this pandemic may kick of changes in the pharma market.
Hydrogen – a Market with Potential
Linde intends to further expand its hydrogen business by investing in electrolysis capacities and infrastructure.
Line Products as a Growth Market
The WeylChem Group of companies consists of seven operating and two R&D sites in Europe and the USA as well as the global sales and marketing platform, WeylChem International.
15.06.2020 • Topics • Innovation
Creating the AI-Powered Future of Chemistry
Molecule.one leverages artificial intelligence (AI) to design novel chemical syntheses. As a response to the outbreak of the Covid-19 pandemic, the Polish start-up based in Warsaw has set out on the mission to accelerate the process of creating medicines.
Predictive Fluid Modelling
Virtual Prototyping of Complex Fluids and Flowing Materials
20.04.2020 • Topics • Innovation
Smart Tools for Chemical Research
Iris.ai was founded at Singularity University at NASA Ames Research Park in 2015. Challenged to come up with an idea that would positively impact the lives of 1 billion people, the team was formed and problem areas were explored.
